ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

ClinicalTrials.gov ID: NCT05755386

Public ClinicalTrials.gov record NCT05755386. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 6:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Iptacopan (LNP023) in Idiopathic Immune-complex-mediated Membranoproliferative Glomerulonephritis (IC-MPGN)

Study identification

NCT ID
NCT05755386
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
106 participants

Conditions and interventions

Conditions

Interventions

  • Placebo Drug
  • iptacopan Drug

Drug

Eligibility (public fields only)

Age range
12 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 1, 2023
Primary completion
Oct 26, 2028
Completion
May 30, 2029
Last update posted
Apr 28, 2026

2023 – 2029

United States locations

U.S. sites
21
U.S. states
15
U.S. cities
20
Facility City State ZIP Site status
Ronald Reagan UCLA Medical Center Los Angeles California 90095 Recruiting
Univ Cali Irvine ALS Neuromuscular Orange California 92868 Recruiting
UCSF San Francisco California 94115 Recruiting
Olive View UCLA Medical Center Sylmar California 91342 Recruiting
Childrens Hospital Colorado Aurora Colorado 80045 Recruiting
Nicklaus Childrens Hospital Miami Florida 33155 Recruiting
Massachusetts General Hospital Boston Massachusetts 02114 Recruiting
Boston Univ School of Medicine Boston Massachusetts 02118 Recruiting
University of Minnesota Minneapolis Minnesota 55455 Recruiting
Washington University in St Louis St Louis Missouri 63110 Recruiting
University of New Mexico Albuquerque New Mexico 87131-0001 Recruiting
Col Uni Med Center New York Presby New York New York 10032 Recruiting
University Of Cincinnati Cincinnati Ohio 45267 Recruiting
OHSU Dept of Nephrology Portland Oregon 97239 Recruiting
Univ of Pennsylvania Medical Center Philadelphia Pennsylvania 19104 Recruiting
MUSC Health Lancaster Med Ctr Lancaster South Carolina 29720 Recruiting
UT Southwestern Medical Center Dallas Texas 75235 Recruiting
Prolato Clinical Research Center Houston Texas 77054 Recruiting
Baylor Scott and White Research Temple Texas 76502 Recruiting
University of Utah Salt Lake City Utah 84113 Recruiting
University of Wisconsin Madison Wisconsin 53792 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 106 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05755386, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 28, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05755386 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →